Intrinsiqs

Is Telix Pharmaceuticals Limited overvalued?

Telix Pharmaceuticals Limited (TLX) — key valuation metrics and fundamentals.

No verdict
Price
$11.82
Fair value
Current P/E
Normal P/E
Market cap
$4.00B
Dividend yield
0.0%
Return on equity
-1.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TLX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.